entertainment -WSS

entertainment

author：entertainment 2025-10-01 17:18:54 - browse：98241

Adam's take main illustration — Molly Ferguson/STAT

Annovis Bio had my biotech bull%^&! meter running red after it made a late change to the design of a Phase 3 study in Parkinson’s disease. But then I got an extraordinary explanation from CEO Maria Maccecchini. Now, I’m less worried about data spin because, by her own admission, the odds that the study succeeds, post endpoint change, are a lot lower.

Results from the completed Parkinson’s study, which is investigating Annovis’ drug called buntanetap, are well past due because of what the company has described as ongoing “data cleaning efforts.” The delay was announced on Jan. 24. Two weeks later, on Feb. 6, the primary efficacy endpoint of the study was changed, according to an update posted to the U.S. government’s clinical trials database.

Red flag, I thought, until I emailed Maccecchini, asking for an explanation. In response, she told me Annovis made the key endpoint change in August, based on a recommendation from officials at the Food and Drug Administration after the agency had reviewed data from an interim analysis of the study. It took the company another six months to update the study design in the ClinicalTrials.gov database, for reasons she did not explain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Gene therapy has helped boys walk. Can scientists keep it that way?

WSS

Why drug prescriptions should include diagnoses

CDC recommends RSV monoclonal antibody for infants

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

What would happen to your eyes if you looked at the solar eclipse?

Group behind ProMed defends move to subscription

Why we need to separate burnout from moral injury in health care

entertainment

entertainment

Wikipedia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The science behind Janet Jackson's pregnancy at 49

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

CDC recommends RSV monoclonal antibody for infants

How one medical school became remarkably diverse

Why drug prescriptions should include diagnoses

Malaria cases in Florida and Texas: Here’s what you need to know

Disclosing genetic information: not as worrisome as once feared

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

#NeedHerScience: shining a light on gender disparities in medicine

leisure time

Flint parents haunted by uncertainty, fears of lead poisoning

Heart disease in astronauts blamed on cosmic radiation

Heart disease in astronauts blamed on cosmic radiation

3 hurdles to bringing medical devices to the U.S. market

Colonoscopy at 40? Study finds a possible benefit

Why drug prescriptions should include diagnoses

explore

focus

Wikipedia

Wikipedia